Magentiq Eye
Improving Colonoscopy through AI
Startup A Health Tech & Life Sciences Est. 2014
Total Raised
$6.1M
A
Last Round
Undisclosed
9 rounds
Investors
8
7 public
Team
1
11-50 employees
Confidence
100/100
News
3
articles
Patents
1
About
Magentiq Eye offers a groundbreaking AI aided colonoscopy solution. The company uses the growing power of deep learning, image processing, and video processing to help doctors become more accurate and effective, potentially saving millions of lives and billions of dollars. The company’s first product is MAGENTIQ-COLO, which is used to increase adenoma (polyp) detection rates and the overall quality of colonoscopy exams. MAGENTIQ-COLO is a real-time adjunct to the colonoscopy device that points out suspicious locations of polyps in the videos, thereby helping doctors reduce their polyp miss-rates. Given the large population that undergoes colonoscopy annually, even a modest decrease in polyp miss-rates has the potential to save many lives. MAGENTIQ-COLO has received the CE mark and FDA clearance. It also completed a successful multi-center international clinical trial to attain clearance for marketing in the USA. Its next version includes additional features such as polyp size estimation, polyp characterization, and additional quality measurements.
Classification
Sector
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Core Technology
Artificial IntelligenceDeep LearningComputer VisionPlatforms & InterfacesSoftware
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
medical-devicesimage-processingendoscopyvideocolonoscopyreal-timediagnosticsdata-analyticsgastroenterologydigital-healthcaresoftware-developmentbig-datadecision-supportcanceroptronics
Funding & Events
May 2017
Non-equity $25K
American Medical Company
Jun 2018
Seed $500K
NextLeap Ventures, Norgine Ventures
Jul 2025
A Round Undisclosed
aMoon Fund, Nova Capital Management, Nina Capital, Ron Doornink, Sake Bosch
Jul 2021
Seed $1.8M
Salida BV, Ron Doornink, Norgine Ventures
Jul 2020
Non-equity $1.16M
Jan 2019
Non-equity $57K
EU Horizon 2020
Jan 2019
Non-equity $435K
Dec 2023
SAFE $2M
Nina Capital
Dec 2016
Non-equity $120K
Office of the Chief Scientist
News (3)
Feb 25, 2024 · nocamels.com
growth-positive
Israeli Colonoscopy Tech Gets Approval From Top Medical Journal
Customers
growth-positive
Magentiq's AI-aided colonoscopy tool increases adenoma detection by 7%
Customers
Jul 31, 2023 · www.prnewswire.com
growth-positive
FDA Authorizes Marketing of MAGENTIQ-COLO™, a Cutting-Edge AI Gastrointestinal Lesion Software Detection System that Helps Detect Lesions in Real Time During Colonoscopy Procedures
CustomersExpand
Details
Product Stage
Released
Employees
11-50
Exact Count
26
District
North District
Founded
2014
Registrar
515124352
Crunchbase
magentiq-eye-ltd
Locations
Ben Gurion Blvd 6, Haifa, Israel
Links
Website
LinkedIn
Twitter
Facebook
Careers
Admin
Last Update
Jul 31, 2025
Verified by
Yanina Wainscheinker
Claimed
Yes
Missing
markets
Team (1)
Dror Zur
Co-founder & CEO
Founder